Management of the infected total elbow arthroplasty.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39481446.
- Also identified by DOI 10.1302/0301-620X.106B11.BJJ-2024-0549.R1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Periprosthetic joint infection represents a devastating complication after total elbow arthroplasty. Several measures can be implemented before, during, and after surgery to decrease infection rates, which exceed 5%. Debridement with antibiotics and implant retention has been reported to be successful in less than one-third of acute infections, but still plays a role. For elbows with well-fixed implants, staged retention seems to be equally successful as the more commonly performed two-stage reimplantation, both with a success rate of 70% to 80%. Permanent resection or even amputation are occasionally considered. Not uncommonly, a second-stage reimplantation requires complex reconstruction of the skeleton with allografts, and the extensor mechanism may also be deficient. Further developments are needed to improve our management of infection after elbow arthroplasty.
Medical subject headings
- Arthroplasty, Replacement, Elbow
- Prosthesis-Related Infections
- Debridement
- Anti-Bacterial Agents
Anatomy
- elbow